The de-extinction company Colossal Biosciences wants to bring back the woolly mammoth—starting with a very furry mouse.
Biohacker Josie Zyner’s new company, Los Angeles Project, is creating a new generation of gene-edited pets.
Startup Canaery is partnering with a US Department of Energy lab to develop neural implants for rats and dogs that are capable of decoding what they smell.
The FDA recently approved a bioengineered blood vessel, which becomes part of a patient’s body over time. It’s designed to help treat victims of traumatic injuries.
When a US research lab accidentally created a sticky web-like substance, it turned to Peter Parker and comic-book lore for inspiration on what to do next.
When a US research lab accidentally created a sticky web-like substance, it turned to Peter Parker and comic-book lore for inspiration on what to do next.
What may be the first commercially available book saved in DNA is the latest example of how consumers might use molecular data storage.
The first medical treatment to use Crispr gene editing has been on the market for a year. Its complexity means few patients in the US have received it yet.
A 53-year-old woman was the third to undergo the transplant procedure. Researchers are hoping to monitor the long-term effects.
The genome-editing technology can be supercharged by artificial intelligence—and the results are already being felt.